Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Zachary McCormick

Physical Medicine & Rehabilitation Chicago, IL Medical Doctor

NPI 1154612273 CMS profile 1377794

780 S Federal St, Unit 1201, Chicago, IL 60605

Open in the dashboard

General payments

$289,868

204 records reported · program years 2019–2025

Research payments

$149,668

Paid to them · 28 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,815,882 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Zachary McCormick of Chicago, IL is reported in the CMS Open Payments database as having received $289,868 across 204 general payments and $149,668 in research payments paid to them. Separately, studies naming them as principal investigator received $2,815,882 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,199 6
2025 Research $60,000 2
2024 General $104,368 50
2024 Research $89,668 26
2023 General $77,921 49
2022 General $56,313 54
2021 General $42,600 33
2020 General $4,760 6
2019 General $1,708 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zachary McCormick
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to Zachary McCormick were reported at $2,199. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year Zachary McCormick Physical Medicine & Rehabilitation median Middle half National median
2019 $1,708 $133 $45–$390 $163
2020 $4,760 $88 $29–$272 $114
2021 $42,600 $116 $33–$360 $132
2022 $56,313 $123 $40–$378 $149
2023 $77,921 $131 $43–$396 $160
2024 $104,368 $141 $45–$409 $164
2025 $2,199 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $117,425 76 payments
  2. Scilex Pharmaceuticals Inc. $44,225 6 payments
  3. Avanos Medical $35,539 15 payments
  4. SI-BONE, Inc. $33,852 31 payments
  5. Saol International Limited $19,113 6 payments
  6. Saol Therapeutics Inc. $14,988 4 payments
  7. Pacira Pharmaceuticals Incorporated $7,500 4 payments
  8. Terumo BCT, Inc. $6,050 1 payment
  9. Stratus Medical, LLC $5,926 6 payments
  10. Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,600 3 payments
  11. Other $3,651 52 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $228,061 83 payments
  2. Honoraria $38,803 10 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,425 2 payments
  4. Travel and Lodging $5,985 15 payments
  5. Food and Beverage $5,590 93 payments
  6. Education $4 1 payment
Products named General payments · program years 2019–2025
  1. SPINEJACK Interventional Spine $45,084 30 payments
  2. ZTLido $44,225 6 payments
  3. PCD $38,422 16 payments
  4. COOLIEF* COOLED RADIOFREQUENCY $34,282 11 payments
  5. MULTIGEN 2 $30,747 15 payments
  6. IFUSE IMPLANT $26,235 21 payments
  7. SPINEJACK Spine $21,115 5 payments
  8. Exparel $7,500 4 payments
  9. IFUSE IMPLANT SYSTEM $7,500 7 payments
  10. HARVEST BMAC $6,050 1 payment
  11. Other $34,460 90 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Avanos Medical $149,668 28 payments

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

158

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$1,726

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

7%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 35 $957
Baclofen Generic 47 $362
Gabapentin Generic 26 $195
Pregabalin Generic 19 $113
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $63
Tramadol Hcl Generic 20 $36

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 52 billing codes

Paid by Medicare

$107,302

Medicare's payments for the services billed

Medicare patients

289

Average age 73

Services billed

1,161

181 women, 108 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 69%
Depression 38%
Ischemic heart disease 30%
Osteoporosis 29%
Diabetes 25%
Chronic kidney disease 20%
Atrial fibrillation 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ZTLido
  • Scilex Pharmaceuticals Inc. $17,775
$17,775 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

232 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physical Medicine & Rehabilitation in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record